General Information of Drug (ID: DMKW8LZ)

Drug Name
AdAPT-001
Synonyms AIM-001
Indication
Disease Entry ICD 11 Status REF
Aggressive cancer 2A00-2F9Z Phase 1/2 [1]
Drug Type
Oncolytic virus
Cross-matching ID
TTD ID
DZLH13

References

1 ClinicalTrials.gov (NCT04673942) A Phase 1/2, First in Human, Study to Evaluate the Safety and Tolerability of AdAPT-001 in Subjects With Refractory Solid Tumors. U.S.National Institutes of Health.